Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Colorcon
AstraZeneca
McKinsey
Medtronic

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,028,858

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 10,028,858 protect, and when does it expire?

Patent 10,028,858 protects LILETTA and is included in one NDA.

This patent has twenty-three patent family members in nineteen countries.

Summary for Patent: 10,028,858
Title:Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Abstract: Intrauterine systems and components thereof. The systems include an intrauterine device (IUD), an insertion device or applicator for inserting the IUD into the cervix of a female patient. The insertion device includes an elongated sheath; an elongated inner member positioned within a lumen of the elongated sheath; a handle with one or more elongated guides; and a moveable sheath slider. Additionally, methods related to the insertion procedure, and methods of manufacture for the insertion device.
Inventor(s): Deckman; Rob (San Bruno, CA), Repp; Richard E. (San Jose, CA), Guyer; Curt (Dublin, CA), Westendorf; Justin (Santa Clara, CA), Parmer; Timothy (Brooklyn Park, MN)
Assignee: Medicines360 (San Francisco, CA)
Application Number:13/539,843
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 10,028,858

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Medicines360 LILETTA levonorgestrel INTRAUTERINE DEVICE;INTRAUTERINE 206229-001 Feb 26, 2015 RX No No   Start Trial   Start Trial Y A METHOD FOR PREVENTION OF PREGNANCY   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Express Scripts
McKinsey
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.